• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION UNKNOWN ENTERRA NEUROSTIMULATOR; INTESTINAL STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION UNKNOWN ENTERRA NEUROSTIMULATOR; INTESTINAL STIMULATOR Back to Search Results
Model Number NEU_ENTERRA_INS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems High Blood Pressure/ Hypertension (1908); Nausea (1970); Vomiting (2144); Constipation (3274)
Event Date 10/08/2015
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: product id 4351, product type: lead.(b)(4).
 
Event Description
A healthcare provider (hcp) for a clinical study reported the patient remained hospitalized after implant for nausea, vomiting, and uncontrolled hypertension due to her inability to take oral medication for hypertension.The patient was admitted to the floor post-operation and given npo (nil per os) status post-surgery secondary to no return of bowel function, the patient spitting up, and she was unable to take her home dose of labetalol and her blood pressure became uncontrollably elevated.The patient was transferred to the surgical intensive care unit and placed on a nicardipine drip.She was also started on erythromycin and thereafter resumed bowel function.Her blood pressure stabilized and she was able to tolerate po (per os - oral administration of medication).Her home po labetalol was restarted and she was then transferred back to the floor.Her blood pressure was stable on the floor and she was deemed stable for discharge with restart of her insulin pump, outpatient endocrine follow up, and follow up with her physician in a week as an outpatient.The problem was not with the patient's device.The nausea, vomiting, and hypertension resolved.If additional information is received, a follow-up report will be sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN ENTERRA NEUROSTIMULATOR
Type of Device
INTESTINAL STIMULATOR
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central avenue ne rcw215
minneapolis MN 55432
Manufacturer Contact
diane wolf
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263987
MDR Report Key5202004
MDR Text Key30451448
Report Number3007566237-2015-03206
Device Sequence Number1
Product Code LNQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H990014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Physician
Type of Report Initial
Report Date 10/14/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEU_ENTERRA_INS
Device Catalogue NumberNEU_ENTERRA_INS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/14/2015
Initial Date FDA Received11/04/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-